Search

Your search keyword '"Kulbe, Hagen"' showing total 284 results
Start Over Author "Kulbe, Hagen"
284 results on '"Kulbe, Hagen"'

1. Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancer

Author

Arends, Christopher Maximilian, Kopp, Klara, Hablesreiter, Raphael, Estrada, Natalia, Christen, Friederike, Moll, Ute Martha, Zeillinger, Robert, Schmitt, Wolfgang Daniel, Sehouli, Jalid, Kulbe, Hagen, Fleischmann, Maximilian, Ray-Coquard, Isabelle, Zeimet, Alain, Raspagliesi, Francesco, Zamagni, Claudio, Vergote, Ignace, Lorusso, Domenica, Concin, Nicole, Bullinger, Lars, Braicu, Elena Ioana, and Damm, Frederik

Published
2024
Full Text
View/download PDF

2. AHRR and SFRP2 in primary versus recurrent high-grade serous ovarian carcinoma and their prognostic implication

Author

Monjé, Nanna, Dragomir, Mihnea P., Sinn, Bruno V., Hoffmann, Inga, Makhmut, Anuar, Simon, Tincy, Kunze, Catarina A., Ihlow, Jana, Schmitt, Wolfgang D., Pohl, Jonathan, Piwonski, Iris, Marchenko, Sofya, Keunecke, Carlotta, Calina, Teodor G., Tiso, Francesca, Kulbe, Hagen, Kreuzinger, Caroline, Cacsire Castillo-Tong, Dan, Sehouli, Jalid, Braicu, Elena I., Denkert, Carsten, Darb-Esfahani, Silvia, Kübler, Kirsten, Capper, David, Coscia, Fabian, Morkel, Markus, Horst, David, Sers, Christine, and Taube, Eliane T.

Published
2024
Full Text
View/download PDF

3. Correction: Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancer

Author

Arends, Christopher Maximilian, Kopp, Klara, Hablesreiter, Raphael, Estrada, Natalia, Christen, Friederike, Moll, Ute Martha, Zeillinger, Robert, Schmitt, Wolfgang Daniel, Sehouli, Jalid, Kulbe, Hagen, Fleischmann, Maximilian, Ray-Coquard, Isabelle, Zeimet, Alain, Raspagliesi, Francesco, Zamagni, Claudio, Vergote, Ignace, Lorusso, Domenica, Concin, Nicole, Bullinger, Lars, Braicu, Elena Ioana, and Damm, Frederik

Published
2024
Full Text
View/download PDF

5. High EVI1 and PARP1 expression as favourable prognostic markers in high-grade serous ovarian carcinoma

Author

Jank, Paul, Leichsenring, Jonas, Kolb, Svenja, Hoffmann, Inga, Bischoff, Philip, Kunze, Catarina Alisa, Dragomir, Mihnea P., Gleitsmann, Moritz, Jesinghaus, Moritz, Schmitt, Wolfgang D., Kulbe, Hagen, Sers, Christine, Stenzinger, Albrecht, Sehouli, Jalid, Braicu, Ioana Elena, Westhoff, Christina, Horst, David, Denkert, Carsten, Gröschel, Stefan, and Taube, Eliane T.

Published
2023
Full Text
View/download PDF

6. LRP1B—a prognostic marker in tubo-ovarian high-grade serous carcinoma

Author

Kolb, Svenja, Hoffmann, Inga, Monjé, Nanna, Dragomir, Mihnea P., Jank, Paul, Bischoff, Philip, Keunecke, Carlotta, Pohl, Jonathan, Kunze, Catarina Alisa, Marchenko, Sofya, Schmitt, Wolfgang D., Kulbe, Hagen, Sers, Christine, Sehouli, Jalid, Braicu, Elena Ioana, Denkert, Carsten, Darb-Esfahani, Silvia, Horst, David, Sinn, Bruno V., and Taube, Eliane T.

Published
2023
Full Text
View/download PDF

7. Increased expression of IDO1 is associated with improved survival and increased number of TILs in patients with high-grade serous ovarian cancer

Author

Hoffmann, Inga, Dragomir, Mihnea P., Monjé, Nanna, Keunecke, Carlotta, Kunze, Catarina Alisa, Schallenberg, Simon, Marchenko, Sofya, Schmitt, Wolfgang D., Kulbe, Hagen, Sehouli, Jalid, Braicu, Ioana Elena, Jank, Paul, Denkert, Carsten, Darb-Esfahani, Silvia, Horst, David, Sinn, Bruno V., Sers, Christine, Bischoff, Philip, and Taube, Eliane T.

Published
2023
Full Text
View/download PDF

8. Impact of BRCA Mutation Status on Tumor Dissemination Pattern, Surgical Outcome and Patient Survival in Primary and Recurrent High-Grade Serous Ovarian Cancer: A Multicenter Retrospective Study by the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium

Author

Glajzer, Jacek, Castillo-Tong, Dan Cacsire, Richter, Rolf, Vergote, Ignace, Kulbe, Hagen, Vanderstichele, Adriaan, Ruscito, Ilary, Trillsch, Fabian, Mustea, Alexander, Kreuzinger, Caroline, Gourley, Charlie, Gabra, Hani, Taube, Eliane T., Dorigo, Oliver, Horst, David, Keunecke, Carlotta, Baum, Joanna, Angelotti, Timothy, Sehouli, Jalid, and Braicu, Elena Ioana

Published
2023
Full Text
View/download PDF

9. Predictive biomarker for surgical outcome in patients with advanced primary high-grade serous ovarian cancer. Are we there yet? An analysis of the prospective biobank for ovarian cancer

Author

Keunecke, Carlotta, Kulbe, Hagen, Dreher, Felix, Taube, Eliane T., Chekerov, Radoslav, Horst, David, Hummel, Michael, Kessler, Thomas, Pietzner, Klaus, Kassuhn, Wanja, Heitz, Florian, Muallem, Mustafa Z., Lang, Susan M., Vergote, Ignace, Dorigo, Oliver, Lammert, Hedwig, du Bois, Andreas, Angelotti, Tim, Fotopoulou, Christina, Sehouli, Jalid, and Braicu, Elena I.

Published
2022
Full Text
View/download PDF

10. ASO Visual Abstract: Impact of BRCA Mutation Status on Tumor Dissemination Pattern, Surgical Outcome, and Patient Survival in Primary and Recurrent High-Grade Serous Ovarian Cancer (HGSOC). A Multicenter, Retrospective Study of the Ovarian Cancer Therapy—Innovative Models Prolong Survival (OCTIPS) Consortium

Author

Glajzer, Jacek, Castillo-Tong, Dan Cacsire, Richter, Rolf, Vergote, Ignace, Kulbe, Hagen, Vanderstichele, Adriaan, Ruscito, Ilary, Trillsch, Fabian, Mustea, Alexander, Kreuzinger, Caroline, Gourley, Charlie, Gabra, Hani, Taube, Eliane T., Dorigo, Oliver, Horst, David, Keunecke, Carlotta, Baum, Joanna, Angelotti, Timothy, Sehouli, Jalid, and Braicu, Elena Ioana

Published
2023
Full Text
View/download PDF

11. Pretreatment with methanolic extract of Pistacia lentiscus L. increases sensitivity to DNA damaging drugs in primary high-grade serous ovarian cancer cells

Author

Charid, Imane, Kessler, Mirjana, Darb-Esfahani, Silvia, Zemojtel, Tomasz, Abobaker, Salem, Tyuarets, Sandra, Schrauwen, Stefanine, Atmani-Kilani, Dina, Benaida-Debbache, Nadjet, Schäfer, Reinhold, Castillo-Tong, Dan Cacsire, Atmani, Djebbar, Cherbal, Farid, Amant, Frederic, Sehouli, Jalid, Kulbe, Hagen, and Braicu, Elena I.

Published
2020
Full Text
View/download PDF

15. Dynamics of the Intratumoral Immune Response during Progression of High-Grade Serous Ovarian Cancer

Author

Stanske, Mandy, Wienert, Stephan, Castillo-Tong, Dan Cacsire, Kreuzinger, Caroline, Vergote, Ignace, Lambrechts, Sandrijne, Gabra, Hani, Gourley, Charlie, Ganapathi, Ram N., Kolaschinski, Ivonne, Budczies, Jan, Sehouli, Jalid, Ruscito, Ilary, Denkert, Carsten, Kulbe, Hagen, Schmitt, Wolfgang, Jöhrens, Korinna, Braicu, Ioana, and Darb-Esfahani, Silvia

Published
2018
Full Text
View/download PDF

16. Vascular endothelial growth factor receptor 2 (VEGFR2) correlates with long-term survival in patients with advanced high-grade serous ovarian cancer (HGSOC): a study from the Tumor Bank Ovarian Cancer (TOC) Consortium

Author

Guan, Jun, Darb-Esfahani, Silvia, Richter, Rolf, Taube, Eliane T., Ruscito, Ilary, Mahner, Sven, Woelber, Linn, Prieske, Katharina, Concin, Nicole, Vergote, Ignace, Van Nieuwenhuysen, Els, Achimas-Cadariu, Patriciu, Glajzer, Joanna, Woopen, Hannah, Stanske, Mandy, Kulbe, Hagen, Denkert, Carsten, Sehouli, Jalid, and Braicu, Elena Ioana

Published
2019
Full Text
View/download PDF

18. Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy–Innovative Models Prolong Survival (OCTIPS) Consortium

Author

Ruscito, Ilary, Cacsire Castillo-Tong, Dan, Vergote, Ignace, Ignat, Iulia, Stanske, Mandy, Vanderstichele, Adriaan, Ganapathi, Ram N., Glajzer, Jacek, Kulbe, Hagen, Trillsch, Fabian, Mustea, Alexander, Kreuzinger, Caroline, Benedetti Panici, Pierluigi, Gourley, Charlie, Gabra, Hani, Kessler, Mirjana, Sehouli, Jalid, Darb-Esfahani, Silvia, and Braicu, Elena Ioana

Published
2017
Full Text
View/download PDF

21. Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact (an OCTIPS Consortium study).

Author

Ruscito, Ilary, Cacsire Castillo-Tong, Dan, Vergote, Ignace, Ignat, Iulia, Stanske, Mandy, Vanderstichele, Adriaan, Glajzer, Jacek, Kulbe, Hagen, Trillsch, Fabian, Mustea, Alexander, Kreuzinger, Caroline, Benedetti Panici, Pierluigi, Gourley, Charlie, Gabra, Hani, Nuti, Marianna, Taube, Eliane T., Kessler, Mirjana, Sehouli, Jalid, Darb-Esfahani, Silvia, and Braicu, Elena Ioana

Published
2018
Full Text
View/download PDF

23. In Silico Analysis Predicts Nuclear Factors NR2F6 and YAP1 as Mesenchymal Subtype-Specific Therapeutic Targets for Ovarian Cancer Patients

Author

Kassuhn, Wanja, Rodriguez Cutillas, Pedro, Kessler, Mirjana, Sehouli, Jalid, Braicu, Elena I., Blüthgen, Nils, and Kulbe, Hagen

Subjects
molecular subtypes, ovarian cancer, therapeutics, ddc:610, tumour microenvironment, 610 Medizin und Gesundheit, cell–cell communication
Abstract

Background: Tumour heterogeneity in high-grade serous ovarian cancer (HGSOC) is a proposed cause of acquired resistance to treatment and high rates of relapse. Among the four distinct molecular subtypes of HGSOC, the mesenchymal subtype (MES) has been observed with high frequency in several study cohorts. Moreover, it exhibits aggressive characteristics with poor prognosis. The failure to adequately exploit such subtypes for treatment results in high mortality rates, highlighting the need for effective targeted therapeutic strategies that follow the idea of personalized medicine (PM). Methods: As a proof-of-concept, bulk and single-cell RNA data were used to characterize the distinct composition of the tumour microenvironment (TME), as well as the cell–cell communication and its effects on downstream transcription of MES. Moreover, transcription factor activity contextualized with causal inference analysis identified novel therapeutic targets with potential causal impact on transcription factor dysregulation promoting the malignant phenotype. Findings: Fibroblast and macrophage phenotypes are of utmost importance for the complex intercellular crosstalk of MES. Specifically, tumour-associated macrophages were identified as the source of interleukin 1 beta (IL1B), a signalling molecule with significant impact on downstream transcription in tumour cells. Likewise, signalling molecules tumour necrosis factor (TNF), transforming growth factor beta (TGFB1), and C-X-C motif chemokine 12 (CXCL12) were prominent drivers of downstream gene expression associated with multiple cancer hallmarks. Furthermore, several consistently hyperactivated transcription factors were identified as potential sources for treatment opportunities. Finally, causal inference analysis identified Yes-associated protein 1 (YAP1) and Nuclear Receptor Subfamily 2 Group F Member 6 (NR2F6) as novel therapeutic targets in MES, verified in an independent dataset. Interpretation: By utilizing a sophisticated bioinformatics approach, several candidates for treatment opportunities, including YAP1 and NR2F6 were identified. These candidates represent signalling regulators within the cellular network of the MES. Hence, further studies to confirm these candidates as potential targeted therapies in PM are warranted. Deutsche Krebshilfe

Published
2023
Full Text
View/download PDF

24. Supplementary Table S5 from IL6-STAT3-HIF Signaling and Therapeutic Response to the Angiogenesis Inhibitor Sunitinib in Ovarian Clear Cell Cancer

Author

Anglesio, Michael S., primary, George, Joshy, primary, Kulbe, Hagen, primary, Friedlander, Michael, primary, Rischin, Danny, primary, Lemech, Charlotte, primary, Power, Jeremy, primary, Coward, Jermaine, primary, Cowin, Prue A., primary, House, Colin M., primary, Chakravarty, Probir, primary, Gorringe, Kylie L., primary, Campbell, Ian G., primary, Okamoto, Aikou, primary, Birrer, Michael J., primary, Huntsman, David G., primary, de Fazio, Anna, primary, Kalloger, Steve E., primary, Balkwill, Frances, primary, Gilks, C. Blake, primary, and Bowtell, David D., primary

Published
2023
Full Text
View/download PDF

26. Supplementary Tables 1-3 from Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer

Author

Coward, Jermaine, primary, Kulbe, Hagen, primary, Chakravarty, Probir, primary, Leader, David, primary, Vassileva, Vessela, primary, Leinster, D. Andrew, primary, Thompson, Richard, primary, Schioppa, Tiziana, primary, Nemeth, Jeffery, primary, Vermeulen, Jessica, primary, Singh, Naveena, primary, Avril, Norbert, primary, Cummings, Jeff, primary, Rexhepaj, Elton, primary, Jirström, Karin, primary, Gallagher, William M., primary, Brennan, Donal J., primary, McNeish, Iain A., primary, and Balkwill, Frances R., primary

Published
2023
Full Text
View/download PDF

27. Supplementary Figure 3 from Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer

Author

Coward, Jermaine, primary, Kulbe, Hagen, primary, Chakravarty, Probir, primary, Leader, David, primary, Vassileva, Vessela, primary, Leinster, D. Andrew, primary, Thompson, Richard, primary, Schioppa, Tiziana, primary, Nemeth, Jeffery, primary, Vermeulen, Jessica, primary, Singh, Naveena, primary, Avril, Norbert, primary, Cummings, Jeff, primary, Rexhepaj, Elton, primary, Jirström, Karin, primary, Gallagher, William M., primary, Brennan, Donal J., primary, McNeish, Iain A., primary, and Balkwill, Frances R., primary

Published
2023
Full Text
View/download PDF

28. Supplementary Figures S1-S5 from IL6-STAT3-HIF Signaling and Therapeutic Response to the Angiogenesis Inhibitor Sunitinib in Ovarian Clear Cell Cancer

Author

Anglesio, Michael S., primary, George, Joshy, primary, Kulbe, Hagen, primary, Friedlander, Michael, primary, Rischin, Danny, primary, Lemech, Charlotte, primary, Power, Jeremy, primary, Coward, Jermaine, primary, Cowin, Prue A., primary, House, Colin M., primary, Chakravarty, Probir, primary, Gorringe, Kylie L., primary, Campbell, Ian G., primary, Okamoto, Aikou, primary, Birrer, Michael J., primary, Huntsman, David G., primary, de Fazio, Anna, primary, Kalloger, Steve E., primary, Balkwill, Frances, primary, Gilks, C. Blake, primary, and Bowtell, David D., primary

Published
2023
Full Text
View/download PDF

29. Supplementary Figure 1 from Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer

Author

Coward, Jermaine, primary, Kulbe, Hagen, primary, Chakravarty, Probir, primary, Leader, David, primary, Vassileva, Vessela, primary, Leinster, D. Andrew, primary, Thompson, Richard, primary, Schioppa, Tiziana, primary, Nemeth, Jeffery, primary, Vermeulen, Jessica, primary, Singh, Naveena, primary, Avril, Norbert, primary, Cummings, Jeff, primary, Rexhepaj, Elton, primary, Jirström, Karin, primary, Gallagher, William M., primary, Brennan, Donal J., primary, McNeish, Iain A., primary, and Balkwill, Frances R., primary

Published
2023
Full Text
View/download PDF

32. Supplementary Methods from IL6-STAT3-HIF Signaling and Therapeutic Response to the Angiogenesis Inhibitor Sunitinib in Ovarian Clear Cell Cancer

Author

Anglesio, Michael S., primary, George, Joshy, primary, Kulbe, Hagen, primary, Friedlander, Michael, primary, Rischin, Danny, primary, Lemech, Charlotte, primary, Power, Jeremy, primary, Coward, Jermaine, primary, Cowin, Prue A., primary, House, Colin M., primary, Chakravarty, Probir, primary, Gorringe, Kylie L., primary, Campbell, Ian G., primary, Okamoto, Aikou, primary, Birrer, Michael J., primary, Huntsman, David G., primary, de Fazio, Anna, primary, Kalloger, Steve E., primary, Balkwill, Frances, primary, Gilks, C. Blake, primary, and Bowtell, David D., primary

Published
2023
Full Text
View/download PDF

33. Supplementary Figure 2 from Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer

Author

Coward, Jermaine, primary, Kulbe, Hagen, primary, Chakravarty, Probir, primary, Leader, David, primary, Vassileva, Vessela, primary, Leinster, D. Andrew, primary, Thompson, Richard, primary, Schioppa, Tiziana, primary, Nemeth, Jeffery, primary, Vermeulen, Jessica, primary, Singh, Naveena, primary, Avril, Norbert, primary, Cummings, Jeff, primary, Rexhepaj, Elton, primary, Jirström, Karin, primary, Gallagher, William M., primary, Brennan, Donal J., primary, McNeish, Iain A., primary, and Balkwill, Frances R., primary

Published
2023
Full Text
View/download PDF

34. Supplementary Table 4 from Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer

Author

Coward, Jermaine, primary, Kulbe, Hagen, primary, Chakravarty, Probir, primary, Leader, David, primary, Vassileva, Vessela, primary, Leinster, D. Andrew, primary, Thompson, Richard, primary, Schioppa, Tiziana, primary, Nemeth, Jeffery, primary, Vermeulen, Jessica, primary, Singh, Naveena, primary, Avril, Norbert, primary, Cummings, Jeff, primary, Rexhepaj, Elton, primary, Jirström, Karin, primary, Gallagher, William M., primary, Brennan, Donal J., primary, McNeish, Iain A., primary, and Balkwill, Frances R., primary

Published
2023
Full Text
View/download PDF

35. Supplementary Figure Legends 1-3 from Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer

Author

Coward, Jermaine, primary, Kulbe, Hagen, primary, Chakravarty, Probir, primary, Leader, David, primary, Vassileva, Vessela, primary, Leinster, D. Andrew, primary, Thompson, Richard, primary, Schioppa, Tiziana, primary, Nemeth, Jeffery, primary, Vermeulen, Jessica, primary, Singh, Naveena, primary, Avril, Norbert, primary, Cummings, Jeff, primary, Rexhepaj, Elton, primary, Jirström, Karin, primary, Gallagher, William M., primary, Brennan, Donal J., primary, McNeish, Iain A., primary, and Balkwill, Frances R., primary

Published
2023
Full Text
View/download PDF

36. Data from A Dynamic Inflammatory Cytokine Network in the Human Ovarian Cancer Microenvironment

Author

Kulbe, Hagen, primary, Chakravarty, Probir, primary, Leinster, D. Andrew, primary, Charles, Kellie A., primary, Kwong, Joseph, primary, Thompson, Richard G., primary, Coward, Jermaine I., primary, Schioppa, Tiziana, primary, Robinson, Stephen C., primary, Gallagher, William M., primary, Galletta, Laura, primary, Salako, Michael A., primary, Smyth, John F., primary, Hagemann, Thorsten, primary, Brennan, Donal J., primary, Bowtell, David D., primary, and Balkwill, Frances R., primary

Published
2023
Full Text
View/download PDF

37. Supplemental Figure Legends from Adaptive Upregulation of EGFR Limits Attenuation of Tumor Growth by Neutralizing IL6 Antibodies, with Implications for Combined Therapy in Ovarian Cancer

Author

Milagre, Carla S., primary, Gopinathan, Ganga, primary, Everitt, Gemma, primary, Thompson, Richard G., primary, Kulbe, Hagen, primary, Zhong, Haihong, primary, Hollingsworth, Robert E., primary, Grose, Richard, primary, Bowtell, David D.L., primary, Hochhauser, Daniel, primary, and Balkwill, Frances R., primary

Published
2023
Full Text
View/download PDF

38. Supplementary Figure 4 from Adaptive Upregulation of EGFR Limits Attenuation of Tumor Growth by Neutralizing IL6 Antibodies, with Implications for Combined Therapy in Ovarian Cancer

Author

Milagre, Carla S., primary, Gopinathan, Ganga, primary, Everitt, Gemma, primary, Thompson, Richard G., primary, Kulbe, Hagen, primary, Zhong, Haihong, primary, Hollingsworth, Robert E., primary, Grose, Richard, primary, Bowtell, David D.L., primary, Hochhauser, Daniel, primary, and Balkwill, Frances R., primary

Published
2023
Full Text
View/download PDF

39. Supplementary Figure 3 from Adaptive Upregulation of EGFR Limits Attenuation of Tumor Growth by Neutralizing IL6 Antibodies, with Implications for Combined Therapy in Ovarian Cancer

Author

Milagre, Carla S., primary, Gopinathan, Ganga, primary, Everitt, Gemma, primary, Thompson, Richard G., primary, Kulbe, Hagen, primary, Zhong, Haihong, primary, Hollingsworth, Robert E., primary, Grose, Richard, primary, Bowtell, David D.L., primary, Hochhauser, Daniel, primary, and Balkwill, Frances R., primary

Published
2023
Full Text
View/download PDF

40. Supplementary Table 2 from A Dynamic Inflammatory Cytokine Network in the Human Ovarian Cancer Microenvironment

Author

Kulbe, Hagen, primary, Chakravarty, Probir, primary, Leinster, D. Andrew, primary, Charles, Kellie A., primary, Kwong, Joseph, primary, Thompson, Richard G., primary, Coward, Jermaine I., primary, Schioppa, Tiziana, primary, Robinson, Stephen C., primary, Gallagher, William M., primary, Galletta, Laura, primary, Salako, Michael A., primary, Smyth, John F., primary, Hagemann, Thorsten, primary, Brennan, Donal J., primary, Bowtell, David D., primary, and Balkwill, Frances R., primary

Published
2023
Full Text
View/download PDF

41. Supplementary Figure Legends 1-4 from A Dynamic Inflammatory Cytokine Network in the Human Ovarian Cancer Microenvironment

Author

Kulbe, Hagen, primary, Chakravarty, Probir, primary, Leinster, D. Andrew, primary, Charles, Kellie A., primary, Kwong, Joseph, primary, Thompson, Richard G., primary, Coward, Jermaine I., primary, Schioppa, Tiziana, primary, Robinson, Stephen C., primary, Gallagher, William M., primary, Galletta, Laura, primary, Salako, Michael A., primary, Smyth, John F., primary, Hagemann, Thorsten, primary, Brennan, Donal J., primary, Bowtell, David D., primary, and Balkwill, Frances R., primary

Published
2023
Full Text
View/download PDF

42. Supplementary Figure 5 from Adaptive Upregulation of EGFR Limits Attenuation of Tumor Growth by Neutralizing IL6 Antibodies, with Implications for Combined Therapy in Ovarian Cancer

Author

Milagre, Carla S., primary, Gopinathan, Ganga, primary, Everitt, Gemma, primary, Thompson, Richard G., primary, Kulbe, Hagen, primary, Zhong, Haihong, primary, Hollingsworth, Robert E., primary, Grose, Richard, primary, Bowtell, David D.L., primary, Hochhauser, Daniel, primary, and Balkwill, Frances R., primary

Published
2023
Full Text
View/download PDF

43. Supplementary Figure 2 from Adaptive Upregulation of EGFR Limits Attenuation of Tumor Growth by Neutralizing IL6 Antibodies, with Implications for Combined Therapy in Ovarian Cancer

Author

Milagre, Carla S., primary, Gopinathan, Ganga, primary, Everitt, Gemma, primary, Thompson, Richard G., primary, Kulbe, Hagen, primary, Zhong, Haihong, primary, Hollingsworth, Robert E., primary, Grose, Richard, primary, Bowtell, David D.L., primary, Hochhauser, Daniel, primary, and Balkwill, Frances R., primary

Published
2023
Full Text
View/download PDF

44. Supplementary Figure 3 from A Dynamic Inflammatory Cytokine Network in the Human Ovarian Cancer Microenvironment

Author

Kulbe, Hagen, primary, Chakravarty, Probir, primary, Leinster, D. Andrew, primary, Charles, Kellie A., primary, Kwong, Joseph, primary, Thompson, Richard G., primary, Coward, Jermaine I., primary, Schioppa, Tiziana, primary, Robinson, Stephen C., primary, Gallagher, William M., primary, Galletta, Laura, primary, Salako, Michael A., primary, Smyth, John F., primary, Hagemann, Thorsten, primary, Brennan, Donal J., primary, Bowtell, David D., primary, and Balkwill, Frances R., primary

Published
2023
Full Text
View/download PDF

45. Supplementary Figure 1 from Adaptive Upregulation of EGFR Limits Attenuation of Tumor Growth by Neutralizing IL6 Antibodies, with Implications for Combined Therapy in Ovarian Cancer

Author

Milagre, Carla S., primary, Gopinathan, Ganga, primary, Everitt, Gemma, primary, Thompson, Richard G., primary, Kulbe, Hagen, primary, Zhong, Haihong, primary, Hollingsworth, Robert E., primary, Grose, Richard, primary, Bowtell, David D.L., primary, Hochhauser, Daniel, primary, and Balkwill, Frances R., primary

Published
2023
Full Text
View/download PDF

46. Supplementary Table 1 from A Dynamic Inflammatory Cytokine Network in the Human Ovarian Cancer Microenvironment

Author

Kulbe, Hagen, primary, Chakravarty, Probir, primary, Leinster, D. Andrew, primary, Charles, Kellie A., primary, Kwong, Joseph, primary, Thompson, Richard G., primary, Coward, Jermaine I., primary, Schioppa, Tiziana, primary, Robinson, Stephen C., primary, Gallagher, William M., primary, Galletta, Laura, primary, Salako, Michael A., primary, Smyth, John F., primary, Hagemann, Thorsten, primary, Brennan, Donal J., primary, Bowtell, David D., primary, and Balkwill, Frances R., primary

Published
2023
Full Text
View/download PDF

47. Supplementary Figure 4 from A Dynamic Inflammatory Cytokine Network in the Human Ovarian Cancer Microenvironment

Author

Kulbe, Hagen, primary, Chakravarty, Probir, primary, Leinster, D. Andrew, primary, Charles, Kellie A., primary, Kwong, Joseph, primary, Thompson, Richard G., primary, Coward, Jermaine I., primary, Schioppa, Tiziana, primary, Robinson, Stephen C., primary, Gallagher, William M., primary, Galletta, Laura, primary, Salako, Michael A., primary, Smyth, John F., primary, Hagemann, Thorsten, primary, Brennan, Donal J., primary, Bowtell, David D., primary, and Balkwill, Frances R., primary

Published
2023
Full Text
View/download PDF

48. Data from Adaptive Upregulation of EGFR Limits Attenuation of Tumor Growth by Neutralizing IL6 Antibodies, with Implications for Combined Therapy in Ovarian Cancer

Author

Milagre, Carla S., primary, Gopinathan, Ganga, primary, Everitt, Gemma, primary, Thompson, Richard G., primary, Kulbe, Hagen, primary, Zhong, Haihong, primary, Hollingsworth, Robert E., primary, Grose, Richard, primary, Bowtell, David D.L., primary, Hochhauser, Daniel, primary, and Balkwill, Frances R., primary

Published
2023
Full Text
View/download PDF

49. Supplementary Figure 2 from A Dynamic Inflammatory Cytokine Network in the Human Ovarian Cancer Microenvironment

Author

Kulbe, Hagen, primary, Chakravarty, Probir, primary, Leinster, D. Andrew, primary, Charles, Kellie A., primary, Kwong, Joseph, primary, Thompson, Richard G., primary, Coward, Jermaine I., primary, Schioppa, Tiziana, primary, Robinson, Stephen C., primary, Gallagher, William M., primary, Galletta, Laura, primary, Salako, Michael A., primary, Smyth, John F., primary, Hagemann, Thorsten, primary, Brennan, Donal J., primary, Bowtell, David D., primary, and Balkwill, Frances R., primary

Published
2023
Full Text
View/download PDF

50. Supplementary Figure 1 from A Dynamic Inflammatory Cytokine Network in the Human Ovarian Cancer Microenvironment

Author

Kulbe, Hagen, primary, Chakravarty, Probir, primary, Leinster, D. Andrew, primary, Charles, Kellie A., primary, Kwong, Joseph, primary, Thompson, Richard G., primary, Coward, Jermaine I., primary, Schioppa, Tiziana, primary, Robinson, Stephen C., primary, Gallagher, William M., primary, Galletta, Laura, primary, Salako, Michael A., primary, Smyth, John F., primary, Hagemann, Thorsten, primary, Brennan, Donal J., primary, Bowtell, David D., primary, and Balkwill, Frances R., primary

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results